Skip to content

Sulfadiazine

Sulfadiazine (sulfadiazine) is a small molecule pharmaceutical. Sulfadiazine was first approved as Sulfadiazine on 1982-01-01. It is used to treat aids-related opportunistic infections, bacterial infections, chancroid, enterobacteriaceae infections, and malaria amongst others in the USA.
Trade Name Sulfadiazine
Common Name Sulfadiazine
Indication aids-related opportunistic infections, bacterial infections, chancroid, enterobacteriaceae infections, malaria, meningococcal meningitis, nocardia infections, otitis media, toxoplasmosis, trachoma, urinary tract infections
Drug Class Antimicrobials (sulfonamides derivatives)
Sulfadiazine
Get full access now